1. Teasing Out Circulating Tumor DNA, Kate Marusina, Ph.D., Genetic Engineering & Biotechnology News February 01, 2018, Vol. 38, No. 3
  2. Isolation of Circulating Plasma Cells from Blood of Patients Diagnosed with Clonal Plasma Cell Disorder using Cell Selection Microfluidics. Integrative Biology, S. A., Kamande, J. Lindell, M. Witek, M. & Voorhees, P. (2018).
  3. Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule. Małgorzata A. Witek1,2,3, Rachel D. Aufforth4, Hong Wang3, Joyce W. Kamande3, Joshua M. Jackson1,2, Swathi R. Pullagurla1,2, Mateusz L. Hupert3,5, Jerry Usary6,7, Weiya Z. Wysham7,8, Dawud Hilliard7,9, Stephanie Montgomery9,10, Victoria Bae-Jump7,8, Lisa A. Carey7,11, Paola A. Gehrig7,8, Matthew I. Milowsky7, Charles M. Perou7, John T. Soper7,8, Young E. Whang7, Jen Jen Yeh4,7,12, George Martin13 and Steven A.
  4. Thermoplastic nanofluidic devices for biomedical applications. Weerakoon-Ratnayake KM1, O'Neil CE2, Uba FI3, Soper SA
  5. Materials and Microfluidics: Enabling the Efficient Isolation and Analysis of Circulating Tumour Cells. Joshua M. Jackson, Małgorzata A. Witeka, Joyce W. Kamandec, and Steven A. Soper
  6. Microfluidics for the Detection of Minimal Residual Disease in Acute Myeloid Leukemia Patients using Circulating Leukemic Cells Selected from Blood Joshua M. Jackson,1,2 James B. Taylor,1,2 Małgorzata A. Witek,2,3 Sally A. Hunsucker,4 Jennifer P. Waugh,5 Yuri Fedoriw,4,5 Thomas C. Shea,5 Steven A. Soper,1,2,3* and Paul M. Armistead4,5*
  7. Cancer: A Global Concern that Demands New Detection Technologies. Steven A. Soper
  8. Improved clinical sensitivity detection of circulating tumor cell assays using a dual selection strategy in women with epithelial ovarian cancer W.Z. Wysham, M.A. Witek, S.A. Soper, P.A. Gehrig, J.E. Stine
  9. Current and future bioanalytical approaches for stroke assessment, Swathi Reddy Pullagurla, S.A. Soper, Mateusz Adamski (2015)
  10. Capture and Enzymatic Release of Circulating Tumor Cells, Soumya Nair, Joshua Jackson, Maggie Witek and S.A. Soper, Chemical Communications 51 (2015) 3266-3269.
  11. Selection of CTC Subpopulations and Their Molecular Profiles, M.A. Witek, M. Hupert, J.J. Yeh, V. Bae-Jump, L. Cary, C. Perou, M. Milowski, W. Young and S.A. Soper, Science Translational Medicine (2015, submitted for publication).
  12. Parallel affinity-based isolation of leukocyte subsets using microfluidics: Applications for stroke diagnosis, S.R. Pullagurla, M.A. Witek, J.M. Jackson, M.M. Lindell, M.L. Hupert, I.V. Nesterova, A.E. Baird and S.A. Soper, Anal. Chem. 86 (2014) 4058-4065.
  13. Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma, Trophy, R.J., Tignanelli, C.J., Kamande, J.W., R.A. Moffitt, S.G. Herrera Loeza, S.A. Soper, J.J. Yen, PLOS ONE 9 (2014) e89474.
  14. Modular microfluidic system for the high throughput selection, enumeration and phenotyping of circulating tumor cells, J. Kamande, H. Wang, J.J. Yeh, M.L. Hupert and S.A. Soper, Anal. Chem. 85 (2013) 9092-9100.
  15. Circulating tumor cells as a possible marker for micrometastatic disease in patients with localized pancreatic cancer, R.D. Aufforth, J.J. Baker, M.A. Witek, J.W. Kamande, H.J. Kim, P. Kuan, S.A. Soper and J.J. Yeh, Annals of Surgical Oncology, 20 (2013) S129.
  16. Circulating tumor cells as a biomarker of response to treatment in patient derived xenograft mouse models of pancreatic adenocarcinoma, R.J. Torphy, C.J. Tignanelli, R.A. Moffitt, S.A. Soper, J.J. Yeh, J. Am. College Surgeons, 217 (2013) S30.
  17. Arrays of high-aspect ratio microchannels for high-throughput isolation of circulating tumor cells, M.L. Hupert, J.M. Jackson, H. Wang, M.A. Witek, J. Kamande, M.I. Milowsky, Y.E. Whang and S.A. Soper, Microsyst. Technol. (2013; DOI 10.1007/s00542-013-1941-6).
  18. High-throughput Selection, Enumeration, Electrokinetic Manipulation, and Molecular Profiling of Low-Abundance Circulating Tumor Cells. U. Dharmisiri, S.A. Soper, Anal. Chem. 83 (2011) 2301-2309.
  19. Microsystems for the Capture of Low Abundant Cells, U. Dharmasiri, A.A. Adams, M. Witek and S.A. Soper, Annual Reviews in Analytical Chemistry 3 (2010) 409-431.
  20. Highly Efficient Capture and Enumeration of Low Abundance Prostate Cancer Cells Using Prostate-Specific Membrane Antigen Aptamers Immobilized to a Polymeric Microfluidic Device. U. Dharmasiri, S. Balamurugan, R.L. McCarley, D. Spivak and S.A. Soper, Electrophoresis 30 (2009) 3289-3300.
  21. Capture and Enumeration of Circulating Tumor Cells from Peripheral Blood using Microfluidics, A.A. Adams, P. Okagbare, J. Feng, R.L. McCarley, M.C. Murphy and S.A. Soper, J. Am. Chem. Soc. 130 (2008) 8633-8641.
  22. Visible Photorelease of Liquid Biopsy Markers following Microfluidic Affinity-Enrichment, (Source 2) Thilanga N. Pahattuge, J. Matt Jackson, Digamber Rane, Harshani Wijerathne, Virginia Brown, Malgorzata A. Witek, Chamani Perera, Richard S. Givens, Blake R. Peterson, and Steven A. Soper